BRCA1 in clinical breast cancer

C. Kent Osborne, Richard M. Elledge, Powel H. Brown, Susan G. Hilsenbeck

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

It should be clear from this review that most, if not all, questions raised at the beginning have only partial answers at best. Significant gaps remain and must await greater understanding of the biological effects of BRCA1 and BRCA2 alterations; the natural history of molecularly defined mutation-associated breast cancer; and the effects of currently proposed prevention and treatment strategies. In this regard, pediatric oncology may provide a useful paradigm. Tremendous advances can be made, even in very rare diseases, by population-wide inclusion of at-risk individuals in standardized management protocols and rigorous collection of associated outcome data.

Original languageEnglish (US)
Pages (from-to)77-88
Number of pages12
JournalBreast Disease
Volume10
Issue number1-2
DOIs
StatePublished - Apr 1998

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'BRCA1 in clinical breast cancer'. Together they form a unique fingerprint.

Cite this